Cyclin D3 predicts disease-free survival in breast cancer

Abstract

BackgroundCyclin D3, which induces progression through the G1 phase of the cell cycle, is a regulator of Cyclin-dependent kinases 4 and 6. Previous studies revealed that abnormal expression of Cyclin D3 was found in many different cancers. However, the role of Cyclin D3 in breast cancer (BC) remains unknown. The aim of this study is to examine the expression pattern of Cyclin D3 in BC and to evaluate its biological role and clinical significance in prognosis prediction. The mechanism involved is also evaluated.MethodsImmunohistochemical staining was used to detect the expression of Cyclin D3. qRT-PCR was used to detect the mRNA level of Cyclin D3 in BC tissues and BC cell lines. Transwell assay was used to examine the role of Cyclin D3 in the migration and invasion of BC cells. Mass Spectrometry was used to search for the interacting protein with Cyclin D3. Co-Immunoprecipitation assay and GST-Pull Down assay were used to validate the interaction of Cyclin D3 and its interaction protein.ResultsThrough detecting Cyclin D3 expression in 243 breast cancer patients’ tissue array, we found Cyclin D3 expression was correlated with ER status (p = 0.000), PR status (p = 0.001), HER2 status (p = 0.002) and tumor differentiation (p = 0.045). The Kaplan–Meier survival curves indicated that the disease free survival (DFS) was significantly poor in high Cyclin D3 expression BC patients (p = 0.004). Furthermore, expression of Cyclin D3 was significantly associated with BC prognosis and was shown to be an independent prognostic marker in breast cancer (p = 0.028). By IHC staining and qPCR detection, Cyclin D3 expression was found to be down-regulated both in BC tissues and in BC cell lines compared with the corresponding normal controls. Further investigation showed Cyclin D3 was involved in the metastasis of BC cells and physically interacted with actin in vivo and in vitro.ConclusionOur studies revealed that Cyclin D3 was upregulated in breast cancer and represented a novel predictor of BC prognosis.Electronic supplementary materialThe online version of this article (doi:10.1186/s12935-015-0245-6) contains supplementary material, which is available to authorized users.

Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta‐analysis

“…The search result yielded 543 studies from PubMed, EMBASE, and Web of Science. Based on the inclusion and exclusion criteria, a total of 14 studies were selected for our meta‐analysis for a further evaluation . The flow chart of the literature search and screening process were shown in Figure .…”

“…miR‐195 targets cyclin D3 to cause cell cycle arrest at the G1 phase, resulting in the reduction of NSCLC cell growth . Furthermore, Chi et al reported that cyclin D3 could serve as an independent prognosis marker in breast cancer …”

Restoration of microRNA-212 Causes a G0/G1 Cell Cycle Arrest and Apoptosis in Adult T-Cell Leukemia/Lymphoma Cells by Repressing CCND3 Expression

“…CCND3-encoding protein cyclin D3 is an important regulator in the progression through the G0/G1 phase of cell cycle 18. Downregulation of cyclin D3 contributes to induction of cell cycle arrest in a variety of cancer cells 19 20.…”

The functions and targets of miR‐212 as a potential biomarker of cancer diagnosis and therapy

“…A study performed by Hai‐hao Wang revealed that overexpression of miR‐212‐5p significantly suppressed the expression of the CCND3 protein by targeting the CCND3 gene and that upregulation of CCND3 positively correlated with cell growth in miR‐212‐5p overexpressing adult T‐cell leukaemia/lymphoma cells, which was accompanied by restoration of cell cycle progression and reduction of apoptotic death . It was also reported that CCND3, encoding protein cyclin D3, played an important role in controlling the advancement through the G0/G1 phase of the cell cycle . XIAP, a key molecule of the cell apoptosis pathway, could prohibit cell apoptosis by inhibiting caspase‐3, caspase‐7 and caspase‐9 .…”

“…25 It was also reported that CCND3, encoding protein cyclin D3, played an important role in controlling the advancement through the G0/G1 phase of the cell cycle. 26 XIAP, a key molecule of the cell apoptosis pathway, could prohibit cell apoptosis by inhibiting caspase-3, caspase-7 and caspase-9. [27][28][29] In renal cell carcinoma (RCC), it was found that miR-…”